Researchers assessed the therapeutic potential of pentraxin 3 inhibition on tyrosine kinase inhibitor-associated cardiotoxicity. They used a human embryonic stem cell line, RUES2, to generate cardiomyocyte cultures for functional testing.
[Biomedicine & Pharmacotherapy]